Stone X Group Inc. Intellia Therapeutics, Inc. Transaction History

Stone X Group Inc.

$1.55 Billion
Q4 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	BUY	$38.49 - $76.21 $289,290 - $572,794	7,516 New	7,516 $389,000
Q1 2022 May 11, 2022	SELL	$58.27 - $118.99 $485,389 - $991,186	-8,330 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$100.76 - $138.36 $168,369 - $231,199	-1,671 Reduced 16.71%	8,330 $985,000
Q3 2021 Oct 20, 2021	SELL	$132.37 - $176.78 $237,074 - $316,612	-1,791 Reduced 15.19%	10,001 $1.34 Million
Q2 2021 Aug 06, 2021	SELL	$60.88 - $161.91 $66,054 - $175,672	-1,085 Reduced 8.43%	11,792 $1.91 Million
Q1 2021 Jun 23, 2021	SELL	$46.59 - $83.68 $46,124 - $82,843	-990 Reduced 7.14%	12,877 $1.03 Million
Q4 2020 Feb 03, 2021	SELL	$18.83 - $63.53 $9,697 - $32,717	-515 Reduced 3.58%	13,867 $754,000
Q3 2020 Nov 12, 2020	SELL	$17.47 - $24.93 $1,747 - $2,493	-100 Reduced 0.69%	14,382 $285,000
Q2 2020 Aug 12, 2020	SELL	$11.14 - $22.87 $5,570 - $11,435	-500 Reduced 3.34%	14,482 $304,000
Q4 2019 Jan 24, 2020	SELL	$10.43 - $17.67 $13,924 - $23,589	-1,335 Reduced 8.18%	14,982 $219,000
Q3 2019 Nov 12, 2019	SELL	$13.07 - $18.51 $6,992 - $9,902	-535 Reduced 3.17%	16,317 $217,000
Q2 2019 Jul 17, 2019	BUY	$13.88 - $18.41 $233,669 - $309,932	16,835 Added 99029.41%	16,852 $276,000
Q2 2019 Jul 12, 2019	SELL	$13.88 - $18.41 $243,385 - $322,819	-17,535 Reduced 99.9%	17 $0
Q1 2019 Apr 05, 2019	SELL	$12.79 - $17.62 $5,665 - $7,805	-443 Reduced 2.46%	17,552 $0
Q4 2018 Jan 15, 2019	SELL	$11.39 - $27.13 $20,536 - $48,915	-1,803 Reduced 9.11%	17,995 $245,000
Q3 2018 Oct 03, 2018	SELL	$25.78 - $32.6 $17,968 - $22,722	-697 Reduced 3.4%	19,798 $0
Q2 2018 Jul 23, 2018	BUY	$20.02 - $30.79 $17,517 - $26,941	875 Added 4.46%	20,495 $561,000
Q1 2018 Apr 19, 2018	BUY	$19.43 - $34.95 $24,384 - $43,862	1,255 Added 6.83%	19,620 $0
Q4 2017 Feb 09, 2018	BUY	$17.39 - $31.12 $319,367 - $571,518	18,365	18,365 $353,000

Others Institutions Holding NTLA

# of Institutions

336

Shares Held

96.1M

Call Options Held

1.06M

Put Options Held

863K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

12.5M
Shares

$115 Million
1.28% of portfolio
Vanguard Group Inc Valley Forge, PA

10.2M
Shares

$93.6 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$88.2 Million
0.0% of portfolio
State Street Corp Boston, MA

5.21M
Shares

$47.8 Million
0.0% of portfolio
Morgan Stanley New York, NY

3.81M
Shares

$35.1 Million
0.0% of portfolio

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $699M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stone X Group Inc. with notifications on news.

Account